Category - New Drugs
FDA Approves Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of Advair Diskus
FDA Approves Osphena (ospemifene) for Moderate to Severe Vaginal Dryness Due to Menopause
FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
FDA Approves Expanded Use of Adacel (Tdap) Vaccine for Repeat Vaccination